Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Inovio Pharmaceuticals, Inc. (INO) had Weighted-Average Shares Outstanding (Diluted) of 46.89M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$3.76M |
|
-- |
|
-- |
|
$17.48M |
|
$-17.48M |
|
$21.24M |
|
$3.76M |
|
$3.76M |
|
$3.76M |
|
$3.76M |
|
$3.76M |
|
$3.76M |
|
$-17.48M |
|
$-16.78M |
|
46.89M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
46.89M |
$0.18 |
|
$0.18 |
|
| Balance Sheet Financials | |
$61.12M |
|
$2.53M |
|
$13.19M |
|
$74.31M |
|
$43.67M |
|
-- |
|
$6.55M |
|
$50.21M |
|
$24.10M |
|
$24.10M |
|
$24.10M |
|
69.00M |
|
| Cash Flow Statement Financials | |
$-88.63M |
|
$14.04M |
|
$53.05M |
|
$65.81M |
|
$44.27M |
|
$-21.54M |
|
$3.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-88.92M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
15.62% |
|
15.62% |
|
5.07% |
|
15.62% |
|
$0.35 |
|
$-1.90 |
|
$-1.89 |
|